Brighter Side of News
HomeGood NewsDiscoveriesInnovationsGlobal GoodHealthGreen ImpactSpaceAICelebritiesGNISubscribe

GLP-1

HealthDiabetes drug Liraglutide cuts migraine days in half

A diabetes drug may cut migraine days by nearly 40%, offering hope for new relief options beyond current treatments.

Joshua Shavit
HealthAlpha cells produce GLP-1, like Ozempic drugs, study findsJoseph Shavit
HealthWeight-loss surgery outperforms GLP-1 drugs for diabetes and obesity, study findsJoshua Shavit
HealthWeight-loss drug Tirzepatide significantly slows breast cancer growth, study finds
HealthBreakthrough new drug stops fat buildup and reverses obesity in clinical trial
HealthCommon diabetes drugs may protect against Alzheimer’s disease
Brighter Side of News
  • Explore
  • About Us
  • News Feed
  • Sitemap
  • Editorial Guidelines
  • Legal
  • Privacy
  • Terms
  • Read More
  • Newsletter Sign-up
  • Flipboard